louisbrulenaudet/clinical-trials huggingface dataset:
Clinical trial NCT04251247: Diagnostic Value of D-dimer/Fibrinogen Ratio in Patients With Acute Aortic Dissection
Official title: Diagnostic Value of D-dimer/Fibrinogen Ratio in Patients With Acute Aortic Dissection
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Aortic Dissection
Pulmonary Embolism
Lead sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital
Sponsor class: OTHER_GOV
First posted: 2020-01-31
Enrollment: 159
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Adults presenting to emergency department with chest pain.

Brief summary: Acute aortic dissection is rare but potentially life-threatening disease with an incidence of 5-30 cases per million, annually. Therefore prompt diagnosis is crucial. D-dimer values have been shown to be useful in the diagnosis of acute aortic dissection. Fibrinogen levels have been shown to be low, normal or high in individuals with acute aortic dissection. This study aims to investigate whether D-dimer/fibrinogen ratio can be valuable for diagnosis of acute aortic dissection.


Eligibility criteria: Inclusion Criteria:

* Diagnosis of acute aortic dissection
* Diagnosis of acute pulmonary embolism
* Diagnosis of non-cardiac chest pain

Exclusion Criteria:

* Any etiology of chest pain other than acute aortic dissection, acute pulmonary embolism, or non-cardiac chest pain
* Participants who do not give consent for enrollment

Primary outcomes:
measure: Acute aortic dissection
timeFrame: 24 hours
Secondary outcomes:
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
city: Istanbul
country: Turkey
facility: Kartal Dr. Lutfi Kirdar Training and Research Hospital
Study officials:
References:
citation: Hajsadeghi S, Kerman SR, Khojandi M, Vaferi H, Ramezani R, Jourshari NM, Mousavi SA, Pouraliakbar H. Accuracy of D-dimer:fibrinogen ratio to diagnose pulmonary thromboembolism in patients admitted to intensive care units. Cardiovasc J Afr. 2012 Sep;23(8):446-56. doi: 10.5830/CVJA-2012-041.
citation: Kara H, Bayir A, Degirmenci S, Kayis SA, Akinci M, Ak A, Celik B, Dogru A, Ozturk B. D-dimer and D-dimer/fibrinogen ratio in predicting pulmonary embolism in patients evaluated in a hospital emergency department. Acta Clin Belg. 2014 Aug;69(4):240-5. doi: 10.1179/2295333714Y.0000000029.
citation: Guan XL, Wang XL, Liu YY, Lan F, Gong M, Li HY, Liu O, Jiang WJ, Liu YM, Zhu JM, Sun LZ, Zhang HJ. Changes in the Hemostatic System of Patients With Acute Aortic Dissection Undergoing Aortic Arch Surgery. Ann Thorac Surg. 2016 Mar;101(3):945-51. doi: 10.1016/j.athoracsur.2015.08.047. Epub 2015 Oct 23.
citation: Eggebrecht H, Naber CK, Bruch C, Kroger K, von Birgelen C, Schmermund A, Wichert M, Bartel T, Mann K, Erbel R. Value of plasma fibrin D-dimers for detection of acute aortic dissection. J Am Coll Cardiol. 2004 Aug 18;44(4):804-9. doi: 10.1016/j.jacc.2004.04.053.
Clinical trial NCT00005347: Framingham Cycle V Offspring-Spouse Nutrition Studies
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Cardiovascular Diseases
Coronary Disease
Heart Diseases
Hypertension
Obesity
Diabetes Mellitus
Atherosclerosis
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sponsor class: NIH
First posted: 2000-05-26
Sex: MALE
Maximum age (years): 100
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no

Brief summary: To examine the associations between diet, nutrition and coronary heart disease (CHD) incidence over seven years using the Cycle V Framingham Offspring/Spouse examination ; to examine the cross-sectional associations between dietary variables and major cardiovascular disease risk factors, to examine changes in dietary behaviors and their determinants over seven years; and to characterize the influences of dietary behavior changes on risk factor status between 1984-88 and 1991-94.

Detailed description: DESIGN NARRATIVE:

The data collection efforts and cross-sectional analyses were carried out among approximately 3800 males and females during the scheduled 1991-1994 Cycle V Framingham Offspring/Spouse study. The secular trend and longitudinal analyses also included data that were collected during the Cycle III Offspring/Spouse studies in 1984-88. Of particular interest were dietary variables which play a major role in serum total cholesterol and lipoprotein regulation. Additional dietary variables which were associated with major cardiovascular risk factors ((elevated) blood pressure, glucose (in)tolerance, (excess) body weight or physical (in)activity, and smoking) or that may predict CHD endpoints were included in the analyses. The potential confounding effects or interactions between dietary and risk factor variables were considered. Separate analyses were carried out in males and females.

The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.

Eligibility criteria: No eligibility criteria

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
References:
citation: Drach GW. Urinary lithiasis. J Urol. 1980 Mar;123(3):348. doi: 10.1016/s0022-5347(17)55928-5. No abstract available.
citation: Posner BM, Franz MM, Quatromoni PA, Gagnon DR, Sytkowski PA, D'Agostino RB, Cupples LA. Secular trends in diet and risk factors for cardiovascular disease: the Framingham Study. J Am Diet Assoc. 1995 Feb;95(2):171-9. doi: 10.1016/S0002-8223(95)00043-7.
Clinical trial NCT00162747: Topical Therapy for Prevention of Infections in Preterm Infants
Official title: Topical Emollient Therapy for Prevention of Infections in Preterm Infants
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE4
Conditions: Skin Diseases
Keywords: Pre-term infants
skin infections
infant skin
Aquaphor
sunflower seed oil
nutrition
skin care
Lead sponsor: Johns Hopkins Bloomberg School of Public Health
Sponsor class: OTHER
First posted: 2005-09-13
Enrollment: 600
Sex: ALL
Minimum age (years): 7
Maximum age (years): 8
Standard ages: CHILD
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: The purpose of this study is to determine how to best take care of the skin of preterm infants in order to prevent infections through the skin.

Detailed description: The skin of babies who are born too early is not mature, which means they are at risk for infections of the skin or in the body. Their skin also become very dry, leading to cracking and breakdown, and this may feel painful or uncomfortable for the infant.

Eligibility criteria: Inclusion Criteria:

* Preterm infants

Exclusion Criteria:

* Full-term infant

Primary outcomes:
measure: Three weeks after application of the intervention, blood will be drawn from those enrolled in the control group.
Secondary outcomes:
measure: Atleast four additional times over the first four weeks of the child's life, the skin will be studied by lightly rubbing the skin with a cotton swab to detect germs on the skin and observing and recording the condition of the baby's skin.
Other outcomes:
Locations:
city: Dhaka
country: Bangladesh
facility: Dhaka Shishu Hospital
Study officials:
affiliation: Johns Hopkins Bloomberg School of Public Health
name: Gary L Darmstadt, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Darmstadt GL, Khan NZ, Rosenstock S, Muslima H, Parveen M, Mahmood W, Ahmed ASMNU, Chowdhury MAKA, Zeger S, Saha SK. Impact of emollient therapy for preterm infants in the neonatal period on child neurodevelopment in Bangladesh: an observational cohort study. J Health Popul Nutr. 2021 May 26;40(1):24. doi: 10.1186/s41043-021-00248-9.
Clinical trial NCT06120647: Molecular Mechanisms Underpinning Sarcopenic Obesity
Official title: Molecular Mechanisms Underpinning Sarcopenic Obesity
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Sarcopenic Obesity
Obesity
Sarcopenia
Aging
Lead sponsor: The Swedish School of Sport and Health Sciences
Sponsor class: OTHER
First posted: 2023-11-07
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Observational model: CASE_CONTROL
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The elderly participants will be community-dwelling living in the greater Stockholm metropolitan area. Participants will be recruited through local senior clubs, online communities, advertisement and word of mouth.

The young participants will be living in the greater Stockholm metropolitan area. Participants will be recruited through university forums, online communities, advertisement and word of mouth.

Brief summary: The coexistence of obesity and sarcopenia results in sarcopenic obesity, a high-risk geriatric condition associated with metabolic perturbations and several co-morbidities. Despite the rising numbers of older adults diagnosed with sarcopenic obesity, few studies have characterized this condition on the muscle cell and systemic level. This study sought to comprehensively assess the influence of sarcopenic obesity on muscle and blood-related parameters and compare it to non-sarocopenic obese and non-sarcopenic lean older adults.


Eligibility criteria: Inclusion Criteria:

* Body fat % in accordance with previously defined criteria
* Free of smoking (since 10 years)
* Able to walk without assistance
* Able to perform bilateral leg extension exercise

Exclusion Criteria:

* History of or present disease of myocardial, vascular, endocrine, hepatic, renal, pulmonary or neuromuscular origin
* Uncontrolled hypo/hypertension
* Use of anticoagulants (Warfarin, Trombyl)
* Use of metformin or other anti-diabetic medications
* Poor appetite and unexplained weight loss (4,5 kg) over the past 6 months
* Active malignancy
* Present infection
* Dementia or delirium
* Other conditions that may interfere with the study protocol in the opinion of the PI

Primary outcomes:
measure: Fiber type-specific cell signalling
timeFrame: 1 hour after ingestion of essential amino acids and resistance exercise
Secondary outcomes:
measure: Skeletal muscle fiber characteristics
timeFrame: 1 hour prior to ingestion of essential amino acids and resistance exercise
measure: Whole body muscle volume
timeFrame: 1 hour
measure: Whole body glucose tolerance
timeFrame: 2 hours
measure: Accelerometer-assessed physical activity levels
timeFrame: 1 week
measure: Isometric and isokinetic leg muscle strength
timeFrame: 1 hour
Other outcomes:
Locations:
city: Stockholm
country: Sweden
facility: The Swedish School of Sport and Health Sciences
Study officials:
affiliation: The Swedish School of Sport and Health Sciences and Karolinska Institute, Stockholm Sweden
name: William Apró, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT02467647: The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy
Official title: Phase 1 Study of the Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE1
Conditions: Multiple Myeloma
Lead sponsor: Wuhan University
Sponsor class: OTHER
Collaborators: name: Tongji Hospital
First posted: 2015-06-10
Enrollment: 500
Sex: ALL
Minimum age (years): 20
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: TREATMENT

Brief summary: To investigate the efficacy of the combination of Thalidomide and Huang-Lian-Jie-Du-Tang on the patients with multiple myeloma in maintain therapy.


Eligibility criteria: Inclusion Criteria:

* patients can take HLJDT

Exclusion Criteria:

* patients can not take HLJDT

Primary outcomes:
measure: Overall survival of patients with multiple myeloma treated with Huang-Lian-Jie-Du-Tang（HLJDT) in maintain therapy
timeFrame: 6 months
Secondary outcomes:
Other outcomes:
Locations:
city: Wuhan
country: China
facility: Wuhan University
state: Hubei
Study officials:
affiliation: Zhongnan Hospital
name: Shangqin Liu, PhD
role: STUDY_CHAIR
References:
citation: Ma Z, Otsuyama K, Liu S, Abroun S, Ishikawa H, Tsuyama N, Obata M, Li FJ, Zheng X, Maki Y, Miyamoto K, Kawano MM. Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood. 2005 Apr 15;105(8):3312-8. doi: 10.1182/blood-2004-10-3915. Epub 2004 Dec 30.
citation: Liu S, Ma Z, Cai H, Li Q, Rong W, Kawano M. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells. Eur J Haematol. 2010 Feb 1;84(2):137-44. doi: 10.1111/j.1600-0609.2009.01365.x. Epub 2009 Oct 28.
Clinical trial NCT05773547: Investigation of the Learning Effect in the Measurement of Circulation in Calf Muscle Using MSOT
Official title: Investigation of the Learning Effect in the Measurement of Circulation in Calf Muscle Using the Multispectral Optoacoustic Tomography
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Multispectral Optoacoustic Tomography
Learning Curve
Image Interpretation, Computer-Assisted
Structural Similarity Index Measure
Keywords: Multispectral Optoacoustic Tomography
Learning Curve
Learning Effect
MSOT
Image Interpretation
Structural Similarity Index Measure
SSIM
Lead sponsor: University Hospital Erlangen
Sponsor class: OTHER
First posted: 2023-03-17
Enrollment: 20
Sex: ALL
Minimum age (years): 18
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The volunteers would be recruited in the clinic where the research takes place, by posters and public speeches. T

Brief summary: The goal of this observational study is to investigate the learning effect in the measurement of micro-circulation in healthy participants using MSOT. The main question it aims to answer are:

If there if a learning effect in MSOT measurement. How long does it takes for the trainees to reach the professional level. Is there a difference between different learning methods? Participants will have to lie on the examination bed while investigator making measurements 7 times in a row on one single location.

Detailed description: Learning effect of MSOT measurements have been observed by previous studies. Therefore, in this study, we aim to quantify the learning effect with circulation-related parameters (Hb, HbO2, SO2) and the similarity between repeated images (structural similarity index measure, SSIM). The measurement would be repeated by 5 different investigators, two of them are professionals, defined as experience over 200 times of MSOT measurement, while the other three are trainees, who haven't performed any MSOT measurements before and each has received one different teaching method, one receiving personal teaching from a professional, one receiving video instruction and one receiving instructions written in paper form.

Eligibility criteria: Inclusion Criteria:

-all those who with the age between 18 and 40 year-old

Exclusion Criteria:

* diabetes mellitus
* hypertension
* cardiovascular diseases
* chronic kidney diseases
* amputation in either lower extremities
* tatoos in either lower extremities

Primary outcomes:
measure: Learning curve in MSOT measurements.
timeFrame: 5 days
measure: Different learning curve between professionals and trainees.
timeFrame: 5 days
Secondary outcomes:
measure: Different learning curve in three different teaching methods
timeFrame: 5 days
Other outcomes:
Locations:
city: Erlangen
country: Germany
facility: University of Erlangen-Nuremberg (FAU), Department of Vascular Surgery
state: Bavaria
Study officials:
References:
Clinical trial NCT00310947: Impact of Patient-Prosthesis-Mismatch on Coronary Flow Reserve
Official title: Impact of Patient-Prosthesis-Mismatch and Aortic Valve Design on Coronary Flow Reserve Following Aortic Valve Replacement
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Coronary Artery Disease
Keywords: Coronary artery disease
Coronary flow reserve
Heart failure
prospective randomised
Lead sponsor: Johann Wolfgang Goethe University Hospital
Sponsor class: OTHER
Collaborators: name: Medtronic
First posted: 2006-04-05
Enrollment: 48
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: NATURAL_HISTORY
Time perspective: PROSPECTIVE

Brief summary: Complete normalization of CFR following AVR for aortic stenosis was observed only for stentless valves. Besides the superior hemodynamic performance this might explain the excellent long term results of this valve design.


Eligibility criteria: Inclusion Criteria:

Aortic valve stenosis

Exclusion Criteria:

Coronary artery disease

Primary outcomes:
Secondary outcomes:
Other outcomes:
Locations:
city: Frankfurt am Main
country: Germany
facility: JW Goethe University Ffm
state: Hessen
Study officials:
affiliation: JW Goethe University Ffm
name: Peter Kleine, MD,PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Bakhtiary F, Schiemann M, Dzemali O, Dogan S, Schachinger V, Ackermann H, Moritz A, Kleine P. Impact of patient-prosthesis mismatch and aortic valve design on coronary flow reserve after aortic valve replacement. J Am Coll Cardiol. 2007 Feb 20;49(7):790-6. doi: 10.1016/j.jacc.2006.10.052. Epub 2007 Feb 5.
Clinical trial NCT01167647: The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective Study
Official title: The Role of Routine Bacterial Culture Including Tuberculosis During
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Tuberculosis
Keywords: Tuberculosis, culture, bronchoscopy
Lead sponsor: Meir Medical Center
Sponsor class: OTHER
First posted: 2010-07-22
Enrollment: 300
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: All patients who will undergo a bronchoscopy examination at pulmonary department in Meir Medical Center and will sign on informed consent.

Brief summary: Many centers routinely culture bronchoscopy samples for bacteria and mycobacteria even when infections including tuberculosis (TB) are not strongly suspected. However, the value of this practice has been poorly defined.

Detailed description: Many centers routinely culture bronchoscopy samples for bacteria and mycobacteria even when infections including tuberculosis (TB) are not strongly suspected. However, the value of this practice has been poorly defined. Unnecessary bronchial cultures of bacteria may lead to over treatment in patients without clinical evidence of infections and may increase the drug resistant strains.

In areas with a high prevalence of TB, routine bronchial cultures may detect clinically unsuspected TB in an appreciable proportion of cases. However, in population with a low prevalence of TB, routine culture of bronchial aspirates may incur an unnecessary expanse and may lead to over diagnosis and over treatment of patients with non pathogenic atypical mycobacteria detected by acid-fast bacillus strains.

Eligibility criteria: Inclusion Criteria:

1. patients who will undergo a bronchoscopy examination at pulmonary department in Meir Medical Center
2. patients who will sign on informed consent. -

Exclusion Criteria:

* 1)age under 18 years

Primary outcomes:
measure: number of positive tuberculosis culture
timeFrame: 12 months
Secondary outcomes:
Other outcomes:
Locations:
city: Kfar Saba
country: Israel
facility: Pulmonary department, Meir Medical Center
Study officials:
affiliation: Meir Medical Center
name: David Shitrit, MD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Talker O, Matveychuk A, Guber A, Mandelbaum-Livnat MM, Varsano S, Shitrit D. Is routine bronchoscopic culture indicated in areas with low tuberculosis prevalence? Int J Tuberc Lung Dis. 2013 Aug;17(8):1100-3. doi: 10.5588/ijtld.12.0997.
Clinical trial NCT00833547: Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia
Official title: Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Schizophrenia
Keywords: sleep
schizophrenia
procedural learning
motor skill
Lead sponsor: Massachusetts General Hospital
Sponsor class: OTHER
Collaborators: name: Sumitomo Pharma America, Inc.
name: Beth Israel Deaconess Medical Center
First posted: 2009-02-02
Enrollment: 25
Sex: ALL
Minimum age (years): 18
Maximum age (years): 45
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL

Brief summary: This study will determine whether eszopiclone will normalize sleep patterns and restore sleep-dependent enhancement of motor skill learning in patients with schizophrenia. The investigators will compare subjects taking a placebo to those taking 3 mg of eszopiclone with regard to: sleep architecture and sleep latency as measured by actigraphy and polysomnography and sleep-dependent motor skill learning.


Eligibility criteria: Inclusion Criteria:

* Clinically stable outpatients with DSM-IV diagnoses of Schizophrenia

Exclusion Criteria:

* History of neurologic or psychiatric disease other than schizophrenia
* Substance abuse or dependence within the past six months
* Other chronic medical conditions that affect sleep
* Pregnancy/breast feeding
* Hepatic impairment
* Treatment with metabolic inhibitors or inducers

Primary outcomes:
measure: Overnight Change on Finger Tapping Task
timeFrame: Train on Day 3 and Test on Day 4 of study (experimental nights)
measure: Sleep Spindle Density During Stage 2 Sleep as Measured by Polysomnography
timeFrame: during two nights in an inpatient Clinical Research Center
Secondary outcomes:
Other outcomes:
Locations:
city: Boston
country: United States
facility: Mass General Hospital
state: Massachusetts
Study officials:
affiliation: Massachusetts General Hospital
name: Dara S. Manoach, PhD
role: PRINCIPAL_INVESTIGATOR
References:
Clinical trial NCT05648747: Pelvic Inflammatory Disease in COVID-19 Era
Official title: Factors Associated With an Unfavorable Clinical Course in Hospitalized Patients With Pelvic Inflammatory Disease in Post Covid 19 Era: a Multicentric Retrospective Cohort Study
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Pelvic Inflammatory Disease
Lead sponsor: Università degli Studi di Ferrara
Sponsor class: OTHER
First posted: 2022-12-13
Enrollment: 300
Sex: FEMALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: A retrospective analysis of pelvic inflammatory disease in women was performed between March 8, 2020 and March 31, 2022 (COVID-19 period). The control period was collected between January , 2020 and December 31, 2019.

Brief summary: The goal of this retrospective cohort study is to to scrutinize the impact of coronavirus disease 2019 (COVID-19) on incidence, demography and patient characteristics in Pelvic Inflammatory Disease comparing with the equal time duration, before and after lockdown was initiated in the country.

The main aim of this study was to compare the demographic and clinical parameters between two cohorts before the onset of lockdown and within the pandemic.


Eligibility criteria: Inclusion Criteria:

Pelvic Inflammatory disease

Exclusion Criteria:

Pregnancy Oncologic disease

Primary outcomes:
measure: Incidence of pelvic inflammatory disease (PID)
timeFrame: baseline, pre-surgery
Secondary outcomes:
Other outcomes:
Locations:
city: Ferrara
country: Italy
facility: Section of Obstetrics and Gynecology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy
Study officials:
References: